Joel Greenblatt’s Twist Bioscience TWST Stock Holding History

Joel Greenblatt’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$326K	Buy	+3,169	New	+$206K	﹤0.01%	1623
2025 Q1	–	Sell	-16,925	Closed	-$787K	–	1663
2024 Q4	$787K	Sell	16,925 -10,813	-39%	-$489K	0.01%	985
2024 Q3	$1.25M	Sell	27,738 -51,314	-65%	-$2.44M	0.01%	857
2024 Q2	$3.9M	Buy	79,052 +18,180	+30%	+$741K	0.05%	494
2024 Q1	$2.09M	Buy	60,872 +5,793	+11%	+$209K	0.03%	638
2023 Q4	$2.03M	Buy	55,079 +12,481	+29%	+$289K	0.04%	602
2023 Q3	$863K	Buy	42,598 +30,537	+253%	+$671K	0.02%	827
2023 Q2	$247K	Buy	+12,061	New	+$181K	0.01%	1178

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Joel Greenblatt's TWST Position: Q2 2026 in Review

Joel Greenblatt opened a new position in Twist Bioscience (TWST) in Q2 2026: 3,169 shares worth $326K. The stake represents ﹤0.01% of the portfolio and ranks #1623 among its holdings. This is a return to the name: Joel Greenblatt previously reported a position in TWST as recently as Q4 2024.

Joel Greenblatt first reported a position in TWST in Q2 2023 and has held it in 8 quarters since. The position peaked at $3.9M in Q2 2024. 334 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Joel Greenblatt held 3,169 shares of Twist Bioscience worth $326K as of Q2 2026.
Twist Bioscience was a new Joel Greenblatt position in Q2 2026.
Twist Bioscience made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1623 holding.
Joel Greenblatt first reported a position in Twist Bioscience in Q2 2023 and has held it in 8 quarters since.
Joel Greenblatt's Twist Bioscience position peaked at $3.9M in Q2 2024.
334 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.